CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 240 enrolled
Drug / intervention
Topical Lidocaine 4% Cream +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01394250
NCT01394250Phase 2Completed
CompareCT.gov

Testing the Efficacy of a Vibrating, Cold Device for Pediatric IV Cannulation Pain Relief in the Emergency Department

Children's Hospital of Philadelphia·interventional·Posted Jul 14, 2011·Updated Sep 16, 2016

In Brief

A Phase 2 clinical trial evaluating Buzzy and Topical Lidocaine 4% Cream for Pain and Anxiety. Completed, enrolled 240 participants across 1 site.

Detailed Summary

The purpose of this study is to test the effectiveness of Buzzy®, a battery-powered reusable device that provides cold and vibration, in reducing the pain associated with intravenous (IV) cannulation. The investigators will investigate if Buzzy® is as effective as topical lidocaine cream in reducing the pain associated with IV cannulation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Anxiety
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJul 14, 2011
Enrollment StartJun 1, 2011
Primary CompletionSep 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 15.0 years ago

Interventions

Buzzydevice

Cold, Vibrational Device

Topical Lidocaine 4% Creamdrug

Applied to anticipated IV site at least 30 minutes prior to cannulation.